Pharmacokinetics of mefloquine in children aged 6 to 24 months
Authors:
- 1 October 1992
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 17 (4) , 275-279
Abstract
Summary The study was carried out in 12 children aged 6 months to 2 years, with uncomplicated falciparum malaria admitted to the Hospital for Tropical Diseases, Bangkok. They were treated with mefloquine in the form of MSP (mefloquine 2S0 mg+sulfadoxine 500 mg +pyrimethamine 25 mg) at a single dose of 25 mg mefloquine base/kg body weight All of them were cured (28 days follow-up) with minimal side effects. Pharmacokinetic parameter determination was carried out in 9 cases. The results revealed that MRT, t1/2 and tmax in this study (children 6–24 months old) are comparable to the values in children aged 5–12 years, but shorter than in adult patients. Cmax and AUC in children 6–24 months old are comparable to those in children of 5–12 years, but much higher than in adult patients. Vz/f values in this study are comparable to those in children 5–12 years old, but lower than in adult patients.Keywords
This publication has 13 references indexed in Scilit:
- Mefloquine sulfadoxine pyrimethamine (MSP) combination delays in vitro emergence of mefloquine resistance in multiple drug resistant Plasmodium falciparum.1989
- Plasma and whole blood mefloquine concentrations during treatment of chloroquine‐resistant falciparum malaria with the combination mefloquine‐sulphadoxine‐pyrimethamine.British Journal of Clinical Pharmacology, 1987
- The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjectsEuropean Journal of Clinical Pharmacology, 1987
- Single-Dose Investigation of Possible Interactions between the Components of the Antimalarial Combination Fansimef®Chemotherapy, 1987
- A phase II clinical trial of mefloquine in Brazilian male subjects.1983
- A phase I clinical trial of mefloquine in Brazilian male subjects.1983
- A PHASE-II CLINICAL-TRIAL OF MEFLOQUINE IN PATIENTS WITH CHLOROQUINE-RESISTANT FALCIPARUM-MALARIA IN THAILAND1983
- The present status of malaria chemotherapy: Mefloquine, a novel antimalarialMedicinal Research Reviews, 1981
- RESISTANCE OF PLASMODIUM FALCIPARUM MALARIA TO SULFADOXINE-PYRIMETHAMINE ('FANSIDAR') IN A REFUGEE CAMP IN THAILANDThe Lancet, 1981
- The inhibitory effect of a drug combination on the development of mefloquine resistance inPlasmodium bergheiPathogens and Global Health, 1980